Nvidia CEO Jensen Huang wants American and Chinese AI companies to work together on safety even as Washington restricts the most capable chips that can be sold into China. In an interview with CNBC, Huang said Nvidia “absolutely must” engage with Chinese AI developers and described the issue as global rather than confined to one country.
The appeal matters because advanced models and computing systems do not stay neatly inside national borders. A dangerous capability discovered by one laboratory can affect developers and users elsewhere. Communication about testing, security failures and safeguards could reduce that risk. Yet Huang’s comments are a policy argument from an executive whose company also has a large commercial interest in the Chinese market. They are not evidence that governments have agreed on common technical standards.
The political setting is unusually complicated. The White House said in September that the United States and China had established a government dialogue to exchange views on the risks and benefits of advanced intelligence systems. That creates a channel for discussion, but it does not settle the separate question of semiconductor access. The Commerce Department said in January that license applications for Nvidia H200, AMD MI325X and similar processors would be reviewed case by case, subject to security, customer-screening and U.S. supply requirements.
Those two tracks can coexist. Governments may discuss safety while continuing to control the hardware used to train and run powerful models. For Nvidia, that distinction is central: safety cooperation can preserve relationships and technical visibility, but only export policy determines which products may be sold and under what conditions.
Investors should therefore treat Huang’s remarks as strategic positioning, not a new revenue catalyst. Nvidia is arguing that excluding Chinese developers from safety conversations could make the global system less predictable. The business consequence remains uncertain because the comments did not include a contract, a regulatory change or a timetable for broader market access. The next concrete evidence will come from government decisions on licenses and from whether the new bilateral dialogue produces operational standards rather than general statements.